drugset / Trial / NCT00699322

Effect of Dipeptidyl Peptidase-IV Inhibitor and Sulfonylurea on Glucose Variability and Oxidative Stress

NCT00699322

RandomizedParallel-groupOpen-labelTreatment

Summary

This research will focus on the effect of Sitagliptin on 24 hour glycemic excursion and improvement of oxidative stress markers compared to long acting sulphonylurea Glimepiride in type 2 diabetic patients with inadequate glycemic control on metformin

Timeline

Start
2008-06
Primary completion
2010-06
Completion
2010-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Glimepiride Small molecule 2 mg Oral
Subject Sitagliptin Small molecule 100 mg Oral